CIPLAMEDICA PHARMACEUTICAL INDUSTRI — Omeprazole Importer Profile
Pharmaceutical Importer · #3 buyer for Omeprazole · $916.7K import value · 22 shipments · YEMEN · DGFT Verified
CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the #3 importer of Omeprazole from India with $916.7K in import value and 22 verified shipments. CIPLAMEDICA PHARMACEUTICAL INDUSTRI holds a 0.1% market share in Omeprazole imports based in YEMEN. The company sources from 1 verified supplier across 17 formulations shipped to 2 countries. Overall, CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports 5 pharmaceutical products worth $2.5M across 4 therapeutic categories.
CIPLAMEDICA PHARMACEUTICAL INDUSTRI — Omeprazole Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Omeprazole to CIPLAMEDICA PHARMACEUTICAL INDUSTRI?
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $916.7K | 22 | 100.0% |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI sources Omeprazole from 1 verified Indian supplier based on 22 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Compare to Nearest Omeprazole Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | DR.REDDY'S LABORATORIES PTY LIMITED | SOUTH AFRICA | $1.1M | 21 | $50.0K |
| 14 | NUTRI-PHARMA USA COMPANY LIMITED | VIETNAM | $900.0K | 18 | $50.0K |
| 3 | CIPLAMEDICA PHARMACEUTICAL INDUSTRI ★ | YEMEN | $700.0K | 14 | $50.0K |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI ranks #3 among 2,858 Omeprazole importers from India. Average shipment value of $50.0K compared to the market average of $34.2K. The closest competitors by value are DR.REDDY'S LABORATORIES PTY LIMITED and NUTRI-PHARMA USA COMPANY LIMITED.
Where Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import Omeprazole To?
Destination countries from 22 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| YEMEN | $558.5K | 12 | 60.9% |
| YEMEN, DEMOCRATIC | $358.2K | 10 | 39.1% |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports Omeprazole to 2 countries. The primary destination is YEMEN receiving 60.9% of shipments worth $558.5K.
What Omeprazole Formulations Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY.16400 PACK 30X10S=4920000 NOS | $200.0K | 4 |
| LOMAC 20 CAPSULES (OMEPRAZOLE 20 MG) (IN | $81.4K | 3 |
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY.16420 PACK 30X10S=4926000 NOS | $50.0K | 1 |
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY.16540 PACK 30 X 10S =4962000 NOS | $50.0K | 1 |
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY.16412 PACK 30X10S=4923600 NOS | $50.0K | 1 |
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY. 16420 PACK 30 X 10S =4926000 NOS | $50.0K | 1 |
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY.16440 PACK 30 X 10S =4932000 NOS | $50.0K | 1 |
| LOMAC 20 CAPSULES OMEPRAZOLE 20 MG DOCUMENT 16416 PACK 30X10S =4924800 NOS | $50.0K | 1 |
| LOMAC 20 CAPSULES (OMEPRAZOLE 20 MG) (INV.QTY.16400 PACK 30X10S=4920000 NOS) | $50.0K | 1 |
| LOMAC 20 CAPSULES (OMEPRAZOLE 20 MG) (INV.QTY.16380 PACK 30X10S=4914000 NOS) | $50.0K | 1 |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports 17 distinct Omeprazole formulations from India. The top formulation is LOMAC 20 CAPSULES OMEPRAZOLE 20 MG INV.QTY.16400 PACK 30X10S with 4 shipments worth $200.0K.
Who Are the Top Buyers of Omeprazole from India and How Much Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import?
India exported $97.8M worth of Omeprazole through 15,000 shipments from 975 suppliers to 179 countries, serving 2,858 buyers globally. CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports $916.7K of this total, accounting for 0.1% of India's Omeprazole exports with 22 shipments from YEMEN. This is verified from 22 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for CIPLAMEDICA PHARMACEUTICAL INDUSTRI's Omeprazole Imports?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI's average Omeprazole order value is $41.7K per consignment, based on 22 shipments totaling $916.7K. CIPLAMEDICA PHARMACEUTICAL INDUSTRI is based in YEMEN and ranks #3 among all Omeprazole importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Omeprazole to CIPLAMEDICA PHARMACEUTICAL INDUSTRI?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI sources Omeprazole from 1 verified Indian supplier: CIPLA LIMITED ($916.7K, 100.0%). This is based on 22 customs records.
How Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Compare to Other Omeprazole Importers?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI ranks #3 among 2,858 Omeprazole importers from India with a 0.1% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($20.4M), GLENMARK PHARMACEUTICALS INC., USA ($17.8M), GLENMARK PHARMACEUTICALS INC USA ($9.7M). CIPLAMEDICA PHARMACEUTICAL INDUSTRI processed 22 shipments from YEMEN.
What Other Gastrointestinal Products Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI also imports these gastrointestinal products. Each links to the detailed product page.
About CIPLAMEDICA PHARMACEUTICAL INDUSTRI
CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports 5 products worth $2.5M. Beyond Omeprazole, top products include Pantoprazole, Carvedilol, Torsemide, Salicylic. View the complete CIPLAMEDICA PHARMACEUTICAL INDUSTRI profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Omeprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Omeprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CIPLAMEDICA PHARMACEUTICAL INDUSTRI matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CIPLAMEDICA PHARMACEUTICAL INDUSTRI's capped import value divided by total capped export value for Omeprazole across all Indian exporters.
- 5.Verified Records: This page is backed by 22 individual customs records matching CIPLAMEDICA PHARMACEUTICAL INDUSTRI importing Omeprazole, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 179+ countries, 2,858+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Omeprazole Import Data for CIPLAMEDICA PHARMACEUTICAL INDUSTRI
Access order-level details, pricing data, supplier connections, and competitive analysis for CIPLAMEDICA PHARMACEUTICAL INDUSTRI's Omeprazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CIPLAMEDICA PHARMACEUTICAL INDUSTRI
Full Company Profile →
5 products · $2.5M total trade · 4 categories
CIPLAMEDICA PHARMACEUTICAL INDUSTRI × Omeprazole
Verified from customs records
Company Overview
Top Products by CIPLAMEDICA PHARMACEUTICAL INDUSTRI
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CIPLAMEDICA PHARMACEUTICAL INDUSTRI.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Omeprazole. For current order-level data, contact TransData Nexus.